NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More

Question 1

What is Allscripts Healthcare Solutions' stock symbol?

Answer

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Question 2

How were Allscripts Healthcare Solutions' earnings last quarter?

Answer

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, May, 3rd. The software maker reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by $0.01. The software maker had revenue of $518.60 million for the quarter, compared to analyst estimates of $527.34 million. Allscripts Healthcare Solutions had a negative net margin of 11.34% and a positive return on equity of 7.80%. Allscripts Healthcare Solutions's revenue for the quarter was up 24.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.13 EPS. View Allscripts Healthcare Solutions' Earnings History.

Question 3

When is Allscripts Healthcare Solutions' next earnings date?

Answer

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

Question 4

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Answer

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.19 billion.

Question 5

What price target have analysts set for MDRX?

Answer

17 equities research analysts have issued 1-year price targets for Allscripts Healthcare Solutions' shares. Their predictions range from $12.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $16.1331 in the next twelve months. View Analyst Ratings for Allscripts Healthcare Solutions.

Question 6

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Answer

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

1. Maxim Group analysts commented, "1Q18 bookings of $304M, up 6.3% y/y, was below our estimate of $315M, but relatively inline with consensus of $305M." (5/4/2018)
2. Cantor Fitzgerald analysts commented, "1Q18 results. Non-GAAP revenue of $518.6 million (+25% y/y) was below consensus of $529 million and our estimate of $533 million. 1Q18 results included EIS revenue of $91 million, which was slightly below 4Q17. Non- GAAP Netsmart revenue was $83 million, representing 11% y/y growth. Non- GAAP gross margin was 47.3%, essentially unchanged from a year earlier. Non- GAAP EPS of $0.16 were in line with our estimate, but $0.01 below consensus. We are not too concerned about the slight miss relative to consensus." (5/3/2018)
3. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)

Question 7

Are investors shorting Allscripts Healthcare Solutions?

Answer

Allscripts Healthcare Solutions saw a decrease in short interest during the month of May. As of May 15th, there was short interest totalling 14,902,389 shares, a decrease of 9.3% from the April 30th total of 16,428,172 shares. Based on an average daily volume of 3,032,726 shares, the days-to-cover ratio is currently 4.9 days. Currently, 8.5% of the shares of the stock are short sold.

Question 8

Who are some of Allscripts Healthcare Solutions' key competitors?

Answer

Some companies that are related to Allscripts Healthcare Solutions include CSRA (CSRA), Scientific Games (SGMS), CACI (CACI), Science Applications International (SAIC), Verint Systems (VRNT), Ebix (EBIX), NetScout Systems (NTCT), Convergys (CVG), Sykes Enterprises (SYKE), Quality Systems (QSII), VASCO Data Security International (VDSI), Unisys (UIS), Ribbon Communications (RBBN), The Keyw (KEYW) and Digimarc (DMRC).

Question 9

Who are Allscripts Healthcare Solutions' key executives?

Answer

Allscripts Healthcare Solutions' management team includes the folowing people:

Mr. Paul M. Black, CEO & Director (Age 60)
Mr. Richard J. Poulton, Pres (Age 53)
Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51)

Question 10

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

Answer

News articles about MDRX stock have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 0.07 on Accern's scale. They also gave news articles about the software maker an impact score of 46.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Question 11

Who are Allscripts Healthcare Solutions' major shareholders?

Answer

Allscripts Healthcare Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.66%), Iridian Asset Management LLC CT (4.02%), Fiduciary Management Inc. WI (3.92%), Fisher Asset Management LLC (2.92%), Silvercrest Asset Management Group LLC (2.49%) and Neuberger Berman Group LLC (1.79%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Question 12

Which major investors are selling Allscripts Healthcare Solutions stock?

Answer

MDRX stock was sold by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Dalton Greiner Hartman Maher & Co., Mesirow Financial Investment Management Equity Management, Monarch Partners Asset Management LLC, Sei Investments Co., Blue Harbour Group L.P., Victory Capital Management Inc. and Hsbc Holdings PLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Question 13

Which major investors are buying Allscripts Healthcare Solutions stock?

Answer

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Silvercrest Asset Management Group LLC, Fort Washington Investment Advisors Inc. OH, UBS Group AG, Federated Investors Inc. PA, Fiduciary Management Inc. WI, Wesbanco Bank Inc. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Question 14

How do I buy shares of Allscripts Healthcare Solutions?

Answer

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

Question 15

What is Allscripts Healthcare Solutions' stock price today?

Answer

One share of MDRX stock can currently be purchased for approximately $12.70.

Question 16

How big of a company is Allscripts Healthcare Solutions?

Answer

Allscripts Healthcare Solutions has a market capitalization of $2.26 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

Question 17

How can I contact Allscripts Healthcare Solutions?

Answer

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		486 (Vote Outperform)
Underperform Votes:		476 (Vote Underperform)
Total Votes:		962

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.71	2.65	2.59	2.53
Ratings Breakdown:	1 Sell Rating(s) 3 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 4 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 5 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 7 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$16.1331	$16.3438	$15.9688	$15.1250
Price Target Upside:	27.03% upside	33.64% upside	15.46% upside	16.89% upside

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/4/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $15.50	High
5/4/2018	Maxim Group	Reiterated Rating	Buy	$18.00	High
5/4/2018	SunTrust Banks	Upgrade	Hold ➝ Buy	$10.78 ➝ $16.13	High
5/3/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$18.00	Medium
4/24/2018	JPMorgan Chase & Co.	Initiated Coverage	Overweight ➝ Overweight	$16.00	High
2/17/2018	Wells Fargo & Co	Set Price Target	Buy	$19.00	High
1/18/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$17.50	Medium
1/11/2018	Royal Bank of Canada	Set Price Target	Buy	$19.00	High
1/4/2018	Citigroup	Initiated Coverage	Buy		Low
11/3/2017	Robert W. Baird	Boost Price Target	Outperform	$16.00 ➝ $17.00	N/A
10/27/2017	KeyCorp	Reiterated Rating	Hold		N/A
10/3/2017	Dougherty & Co	Reiterated Rating	Buy	$15.00 ➝ $16.00	Low
9/11/2017	Cowen	Upgrade	Market Perform ➝ Outperform	$13.00 ➝ $16.00	High
8/25/2017	Jefferies Group	Set Price Target	Buy	$17.00	Low
8/7/2017	Morgan Stanley	Boost Price Target	Underweight	$11.00 ➝ $12.00	Low
7/21/2017	Piper Jaffray Companies	Reiterated Rating	Hold	$14.00	Low
6/19/2017	Leerink Swann	Downgrade	Outperform ➝ Market Perform	$15.00 ➝ $13.00	Medium
3/24/2017	Deutsche Bank	Upgrade	Hold ➝ Buy	$12.50 ➝ $14.00	Low
2/17/2017	Oppenheimer	Reiterated Rating	Hold		N/A
1/8/2017	FBR & Co	Reiterated Rating	Hold	$12.00	N/A
1/3/2017	Canaccord Genuity	Reiterated Rating	Buy	$17.00	N/A
10/23/2016	Argus	Reiterated Rating	Buy	$19.00	N/A
10/5/2016	UBS	Initiated Coverage	Buy	$17.00	N/A
8/5/2016	Goldman Sachs Group	Boost Price Target	Neutral	$14.00 ➝ $16.00	N/A

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$0.11	$0.13	$0.12
Q2 2018	3	$0.13	$0.14	$0.13
Q3 2018	2	$0.15	$0.15	$0.15
Q4 2018	2	$0.16	$0.16	$0.16

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/1/2018		$0.18					N/A
5/3/2018	Q1 2018	$0.17	$0.16	$527.34 million	$518.60 million	View	N/A
2/15/2018	Q4 2017	$0.18	$0.18	$524.05 million	$547.00 million	View	Listen
11/2/2017	Q3 2017	$0.12	$0.12	$429.94 million	$451.20 million	View	N/A
8/3/2017	Q2 2017	$0.15	$0.11	$424.94 million	$426.10 million	View	Listen
5/4/2017	Q1 2017	$0.09	$0.10	$415.20 million	$415.00 million	View	Listen
2/16/2017	Q4 2016	$0.1530	$0.14	$424.11 million	$425.40 million	View	Listen
11/3/2016	Q3	$0.15	$0.14	$414.92 million	$392.40 million	View	Listen
8/4/2016	Q2	$0.14	$0.14	$403.13 million	$386.50 million	View	Listen
5/5/2016	Q1	$0.12	$0.13	$348.51 million	$346.00 million	View	Listen
2/18/2016	Q4	$0.13	$0.13	$357.91 million	$345.60 million	View	Listen
11/5/2015	Q315	$0.12	$0.13	$354.67 million	$355.00 million	View	Listen
8/4/2015	Q215	$0.11	$0.12	$347.13 million	$351.70 million	View	Listen
5/7/2015	Q115	$0.09	$0.08	$344.73 million	$335.00 million	View	Listen
2/26/2015	Q414	$0.09	$0.09	$358.10 million	$343.00 million	View	Listen
11/6/2014	Q314	$0.10	$0.06	$353.00 million	$348.00 million	View	Listen
8/7/2014	Q214	$0.09	$0.09	$353.12 million	$351.30 million	View	Listen
5/8/2014	Q114	$0.07	$0.07	$347.98 billion	$340.30 billion	View	Listen
2/20/2014	Q413	$0.08	$0.08	$343.47 million	$351.00 million	View	Listen
11/7/2013	Q313	$0.08	$0.05	$355.30 million	$334.00 million	View	Listen
8/8/2013	Q2 2013	$0.11	$0.09	$360.00 million	$344.80 million	View	Listen
5/9/2013	Q1 2013	$0.14	$0.09	$368.11 million	$347.10 million	View	Listen
2/19/2013	Q4 2012	$0.21	$0.16	$367.07 million	$367.70 million	View	Listen
11/8/2012	Q312	$0.22	$0.23	$376.97 million	$361.00 million	View	N/A
8/8/2012		$0.18	$0.16			View	N/A
4/26/2012		$0.24	$0.12			View	N/A
2/16/2012		$0.25	$0.25			View	N/A
11/3/2011		$0.22	$0.25			View	N/A
8/2/2011		$0.21	$0.22			View	N/A
5/5/2011		$0.20	$0.21			View	N/A
2/15/2011		$0.18	$0.20			View	N/A
11/8/2010	Q3 2010	$0.16	$0.17			View	N/A
7/20/2010	Q2 2010	$0.15	$0.15			View	N/A
4/7/2010	Q1 2010	$0.14	$0.14			View	N/A
1/10/2010	Q4 2009	$0.13	$0.14			View	N/A
9/29/2009	Q3 2009	$0.13	$0.14			View	N/A
7/20/2009	Q2 2009	$0.14	$0.15			View	N/A
4/2/2009	Q1 2009	$0.12	$0.14			View	N/A
1/8/2009	Q4 2008	$0.12	$0.14			View	N/A
10/23/2008	Q3 2008	$0.13	$0.13			View	N/A
8/5/2008	Q2 2008	$0.09	$0.11			View	N/A
4/30/2008	Q1 2008	$0.10	$0.07			View	N/A
2/13/2008	Q4 2007	$0.12	$0.14			View	N/A

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2018	Richard J Poulton	President	Sell	15,000	$13.53	$202,950.00	505,920
3/14/2018	Brian Farley	EVP	Sell	5,000	$13.73	$68,650.00	240,672
12/15/2017	Richard J Poulton	President	Sell	15,000	$14.26	$213,900.00	1,351,773
12/14/2017	Brian Farley	EVP	Sell	5,000	$14.35	$71,750.00	191,607
12/1/2017	James Hewitt	SVP	Sell	36,796	$14.11	$519,191.56	181,766
9/15/2017	Richard J. Poulton	President	Sell	15,000	$13.56	$203,400.00
9/14/2017	Brian Farley	EVP	Sell	5,000	$13.52	$67,600.00	196,607
9/14/2017	Paul Black	CEO	Sell	15,000	$13.52	$202,800.00
5/16/2017	Richard J Poulton	President	Sell	25,000	$12.06	$301,500.00	412,488
3/23/2017	Brian Farley	SVP	Sell	15,000	$11.63	$174,450.00	217,861
9/15/2016	James Hewitt	SVP	Sell	17,500	$13.00	$227,500.00	158,104
9/15/2016	Paul Black	CEO	Sell	15,000	$13.00	$195,000.00	1,177,009
7/11/2016	Dennis Olis	SVP	Sell	7,000	$14.00	$98,000.00	210,887
7/1/2016	James Hewitt	SVP	Sell	17,500	$13.00	$227,500.00	175,604
6/13/2016	Paul Black	CEO	Sell	15,000	$13.04	$195,600.00	1,197,329
6/13/2016	Richard J Poulton	President	Sell	10,000	$13.03	$130,300.00	343,813
4/7/2016	Dennis Olis	SVP	Sell	25,000	$14.00	$350,000.00	217,887
3/30/2016	James Hewitt	SVP	Sell	17,500	$13.31	$232,925.00	228,104
3/30/2016	Paul Black	CEO	Sell	15,000	$13.31	$199,650.00	1,224,939
3/14/2016	Richard J Poulton	President	Sell	5,000	$12.85	$64,250.00	359,064
8/17/2015	James Hewitt	SVP	Sell	70,000	$14.17	$991,900.00
12/12/2014	Paul Black	CEO	Buy	6,500	$11.51	$74,815.00
11/18/2014	Anita Pramoda	Director	Buy	2,017	$12.25	$24,708.25
11/13/2014	Dennis Chookaszian	Director	Buy	10,000	$12.43	$124,300.00
11/11/2014	Dennis Olis	SVP	Buy	4,400	$11.26	$49,544.00
11/11/2014	Paul Black	CEO	Buy	22,180	$11.26	$249,746.80
11/11/2014	Richard J Poulton	CFO	Buy	4,500	$11.26	$50,670.00
11/11/2014	Stuart L Bascomb	Director	Buy	6,743	$11.26	$75,926.18
8/18/2014	Michael Klayko	Director	Buy	3,500	$14.41	$50,435.00
3/13/2014	Deborah Snow	SVP	Sell	14,740	$18.75	$276,375.00	32,560
11/21/2013	Deborah Snow	SVP	Sell	2,400	$14.70	$35,280.00	33,655
9/9/2013	Clifford B Meltzer	EVP	Sell	35,000	$14.56	$509,600.00
8/15/2013	Michael Klayko	Director	Buy	10,000	$14.80	$148,000.00	24,225
5/30/2013	Deborah Snow	SVP	Sell	1,495	$13.71	$20,496.45
5/20/2013	Stuart L Bascomb	Director	Buy	3,701	$14.02	$51,888.02
5/15/2013	Paul Black	CEO	Buy	7,120	$14.02	$99,822.40
5/14/2013	Steve Shute	VP	Sell	14,612	$14.10	$206,029.20
3/12/2013	Paul Black	CEO	Buy	23,625	$12.69	$299,801.25
3/12/2013	Stuart L Bascomb	Director	Buy	10,000	$12.64	$126,400.00

Date	Headline
	Allscripts' iPro Anesthesia to be Administered by SingHealth finance.yahoo.com - May 24 at 5:29 PM
	Allscripts to deliver anesthesia solution across SingHealth healthcare institutions finance.yahoo.com - May 24 at 8:29 AM
	Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care finance.yahoo.com - May 23 at 8:28 AM
	Allscripts Sunrise(TM) powers The Dudley Group NHS Foundation Trust to transform delivery of care finance.yahoo.com - May 23 at 8:28 AM
	$535.20 Million in Sales Expected for Allscripts (MDRX) This Quarter www.americanbankingnews.com - May 23 at 2:58 AM
	Allscripts (MDRX) versus Ribbon Communications (RBBN) Head to Head Comparison www.americanbankingnews.com - May 22 at 1:33 PM
	$0.18 Earnings Per Share Expected for Allscripts (MDRX) This Quarter www.americanbankingnews.com - May 21 at 3:16 PM
	Allscripts (MDRX) Upgraded by ValuEngine to Hold www.americanbankingnews.com - May 17 at 10:23 PM
	Practice Fusion, an Allscripts company, to Show New Real-World Evidence (RWE) at the 23rd Annual International ... www.globenewswire.com - May 16 at 5:27 PM
	Market Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions ... globenewswire.com - May 16 at 8:36 AM
	Market Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions, Plug Power, GameStop, and Newfield Exploration — Emerging Consolidated Expectations, Analyst Ratings finance.yahoo.com - May 16 at 8:36 AM
	Allscripts (MDRX) Upgraded to Sell by BidaskClub www.americanbankingnews.com - May 15 at 12:37 AM
	Allscripts To Acquire HealthGrid For Mobile Patient Engagement seekingalpha.com - May 10 at 5:43 PM
	Allscripts Expected to Post FY2019 Earnings of $0.71 Per Share (MDRX) www.americanbankingnews.com - May 9 at 9:47 AM
	Allscripts (MDRX) Downgraded by BidaskClub www.americanbankingnews.com - May 8 at 3:58 PM
	Dougherty & Co Comments on Allscripts' Q2 2018 Earnings (MDRX) www.americanbankingnews.com - May 8 at 5:52 AM
	Allscripts (MDRX) Given Average Rating of "Buy" by Analysts www.americanbankingnews.com - May 7 at 7:24 PM
	Allscripts (MDRX) Expected to Announce Quarterly Sales of $543.19 Million www.americanbankingnews.com - May 6 at 4:51 AM
	Allscripts (MDRX) PT Lowered to $15.50 www.americanbankingnews.com - May 5 at 2:59 AM
	Maxim Group Reiterates "Buy" Rating for Allscripts (MDRX) www.americanbankingnews.com - May 4 at 6:05 PM
	Allscripts (MDRX) Raised to "Buy" at SunTrust Banks www.americanbankingnews.com - May 4 at 3:17 PM
	BRIEF-Allscripts Healthcare To Expand Followmyhealth Patient Engagement Platform Portfolio www.reuters.com - May 4 at 8:29 AM
	BRIEF-Allscripts Healthcare Solutions Purchase Price For Health Grid Is $60 Million www.reuters.com - May 4 at 8:29 AM
	Edited Transcript of MDRX earnings conference call or presentation 3-May-18 8:30pm GMT finance.yahoo.com - May 4 at 8:29 AM
	$0.17 EPS Expected for Allscripts (MDRX) This Quarter www.americanbankingnews.com - May 4 at 5:16 AM
	Allscripts (MDRX) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS www.americanbankingnews.com - May 3 at 10:28 PM
	Allscripts (MDRX) Earns Buy Rating from Cantor Fitzgerald www.americanbankingnews.com - May 3 at 10:12 PM
	Allscripts (MDRX) Updates FY18 Earnings Guidance www.americanbankingnews.com - May 3 at 7:12 PM
	BRIEF-Allscripts To Significantly Expand FollowMyHealth Patient Engagement Platform Portfolio Through Acquisition ... www.reuters.com - May 3 at 5:15 PM
	BRIEF-Allscripts Healthcare Q1 GAAP Loss Per Share $0.22 www.reuters.com - May 3 at 5:15 PM
	Allscripts (MDRX) to Buy HealthGrid www.streetinsider.com - May 3 at 5:15 PM
	Allscripts Achieves Top Honors From Hospital Chains, IDNs and Networks for Integrated EHR, Interoperability ... www.prnewswire.com - May 3 at 5:15 PM
	Allscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGrid finance.yahoo.com - May 3 at 5:15 PM
	AllScripts: 1Q Earnings Snapshot finance.yahoo.com - May 3 at 5:15 PM
	Allscripts announces first quarter 2018 results finance.yahoo.com - May 3 at 5:15 PM
	Allscripts to buy HealthGrid seekingalpha.com - May 3 at 4:47 PM
	Allscripts (MDRX) Set to Announce Earnings on Wednesday www.americanbankingnews.com - April 25 at 3:52 AM
	JPMorgan Chase Begins Coverage on Allscripts (MDRX) www.americanbankingnews.com - April 24 at 8:55 AM
	JPMorgan Assumes Allscripts (MDRX) at Overweight www.streetinsider.com - April 24 at 8:28 AM
	Technical Perspectives on Application Software Stocks -- 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYS www.prnewswire.com - April 23 at 8:24 AM
	Analysts Expect Allscripts (MDRX) Will Announce Quarterly Sales of $532.66 Million www.americanbankingnews.com - April 19 at 4:57 AM
	Zacks: Brokerages Anticipate Allscripts (MDRX) Will Post Earnings of $0.17 Per Share www.americanbankingnews.com - April 17 at 1:12 AM
	Allscripts (MDRX) Given Consensus Recommendation of "Hold" by Analysts www.americanbankingnews.com - April 12 at 8:12 PM
	DIGITAL HEALTH BRIEFING: Google, AMA launch interoperability challenge — Doctor On Demand rolls out location ... www.businessinsider.com - April 12 at 8:56 AM
	Short Interest in Allscripts (MDRX) Increases By 29.0% www.americanbankingnews.com - April 12 at 2:17 AM
	Allscripts (MDRX) Lifted to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 11 at 6:45 PM
	Allscripts to release first-quarter 2018 financial results May 3 finance.yahoo.com - April 9 at 5:11 PM
	Dougherty & Co Reiterates Buy Rating for Allscripts (MDRX) www.americanbankingnews.com - April 8 at 10:08 AM
	Cantor Fitzgerald Reiterates Buy Rating for Allscripts (MDRX) www.americanbankingnews.com - April 5 at 1:57 PM
	Allscripts (MDRX) Downgraded by TheStreet www.americanbankingnews.com - April 4 at 12:49 PM

NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive MDRX News and Ratings via Email

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

How were Allscripts Healthcare Solutions' earnings last quarter?

When is Allscripts Healthcare Solutions' next earnings date?

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

What price target have analysts set for MDRX?

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Are investors shorting Allscripts Healthcare Solutions?

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

Who are Allscripts Healthcare Solutions' major shareholders?

Which major investors are selling Allscripts Healthcare Solutions stock?

Which major investors are buying Allscripts Healthcare Solutions stock?

How do I buy shares of Allscripts Healthcare Solutions?

What is Allscripts Healthcare Solutions' stock price today?

How big of a company is Allscripts Healthcare Solutions?

How can I contact Allscripts Healthcare Solutions?

MarketBeat Community Rating for Allscripts Healthcare Solutions (MDRX)

Analyst Ratings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Price Target and Consensus Rating

Allscripts Healthcare Solutions (NASDAQ:MDRX) Consensus Price Target History

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analyst Ratings History

Earnings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings History and Estimates Chart

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings Estimates

Allscripts Healthcare Solutions (NASDAQ MDRX) Earnings History by Quarter

Dividends

Allscripts Healthcare Solutions (NASDAQ:MDRX) Dividend History by Quarter

Insider Trades

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading and Institutional Ownership History

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading History

Headlines

Allscripts Healthcare Solutions (NASDAQ MDRX) News Headlines

SEC Filings

Allscripts Healthcare Solutions (NASDAQ:MDRX) SEC Filings

Social Media

Financials

Allscripts Healthcare Solutions (NASDAQ:MDRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allscripts Healthcare Solutions (NASDAQ MDRX) Stock Chart for Sunday, May, 27, 2018